BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Doxorubicin
,
rs4950928
,
EGFR
,
Metabolism of xenobiotics
,
Obesity
,
Kidney
,
Nosology
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Fas receptor, N-terminal
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Loading...
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Lymphoproliferative disorder
Radiation injury
Injury of eye region
Tuberculin reaction
Pharyngitis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Dapsone
Oxyphenisatin Acetate
nitidine chloride
Metyrapone
NVP-AEW541
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
FIGLA
TGFBR1
RBBP7
RABGGTA
RHO
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Livers and inguinal adipose of diabetic Lepr[db/db] mice treated with rosiglitazone or S compound
L1000 CMAP Prostate cancer VCaP cells with gene overexpression perturbations
L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
Drug target sets for approved compounds
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Fas receptor, N-terminal
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy …
Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Pos…
Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor …
HuMax-CD20 i(Ofatumumab) n Follicular Lymphoma (FL) Patients Refractory to Rituximab
Efficacy and Safety Study of ACZ885 in Patients With Active Recurrent or Chronic TNF-receptor Associ…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ